Literature DB >> 21761202

Predominance of CK2α over CK2α' in the mammalian brain.

Ilaria Ceglia1, Marc Flajolet, Heike Rebholz.   

Abstract

CK2 is a heterotetrameric ubiquitous kinase consisting of two catalytic subunits and two regulatory subunits. The two catalytic subunits, α and α', are highly homologous but differ in their C-terminal regions. It is not known whether CK2α and α' have distinctive substrate specificity, since no α- or α'-specific substrate has been identified. Thus, it is assumed that the two kinase isoforms overlap in their substrate specificity. CK2 protein levels and activity were found to be elevated in the brain when compared to other organs. Here we have studied the protein levels of CK2α and α' isoforms in nine major brain regions. We found that both, CK2α and α', are expressed in all brain regions tested. Whereas CK2α levels do not vary strongly across the regions, CK2α' levels are slightly higher in the cortex and hippocampus than in other regions. Furthermore, we show that CK2α protein levels in the striatum are relatively high when compared to CK2α'. The approximate stoichiometry ratio of CK2α:CK2α' is 8:1. Therefore, one can consider that CK2α levels are predominant in comparison to CK2α' levels throughout the mammalian brain.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21761202     DOI: 10.1007/s11010-011-0963-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

Review 1.  Casein kinase 2 as a potentially important enzyme in the nervous system.

Authors:  P R Blanquet
Journal:  Prog Neurobiol       Date:  2000-02       Impact factor: 11.685

2.  Interactions between protein kinase CK2 and Pin1. Evidence for phosphorylation-dependent interactions.

Authors:  Moira M Messenger; Ronald B Saulnier; Andrew D Gilchrist; Phaedra Diamond; Gary J Gorbsky; David W Litchfield
Journal:  J Biol Chem       Date:  2002-04-08       Impact factor: 5.157

3.  Casein kinase II. cDNA sequences, developmental expression, and tissue distribution of mRNAs for alpha, alpha', and beta subunits of the chicken enzyme.

Authors:  G Maridor; W Park; W Krek; E A Nigg
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

4.  CK2 negatively regulates Galphas signaling.

Authors:  Heike Rebholz; Akinori Nishi; Sabine Liebscher; Angus C Nairn; Marc Flajolet; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-03       Impact factor: 11.205

5.  A specific catalytic subunit isoform of protein kinase CK2 is required for phosphorylation of the repressor Nrg1 in Saccharomyces cerevisiae.

Authors:  Cristin D Berkey; Marian Carlson
Journal:  Curr Genet       Date:  2006-04-11       Impact factor: 3.886

6.  Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.

Authors:  Joel W Slaton; Gretchen M Unger; Daniel T Sloper; Alan T Davis; Khalil Ahmed
Journal:  Mol Cancer Res       Date:  2004-12       Impact factor: 5.852

7.  Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit.

Authors:  X Xu; P A Toselli; L D Russell; D C Seldin
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

8.  Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.

Authors:  I R Rifkin; P L Channavajhala; H L Kiefer; A J Carmack; E Landesman-Bollag; B C Beaudette; B Jersky; D J Salant; S T Ju; A Marshak-Rothstein; D C Seldin
Journal:  J Immunol       Date:  1998-11-15       Impact factor: 5.422

9.  The selectivity of inhibitors of protein kinase CK2: an update.

Authors:  Mario A Pagano; Jenny Bain; Zygmunt Kazimierczuk; Stefania Sarno; Maria Ruzzene; Giovanni Di Maira; Matthew Elliott; Andrzej Orzeszko; Giorgio Cozza; Flavio Meggio; Lorenzo A Pinna
Journal:  Biochem J       Date:  2008-11-01       Impact factor: 3.857

10.  Aberrant casein kinase II in Alzheimer's disease.

Authors:  D S Iimoto; E Masliah; R DeTeresa; R D Terry; T Saitoh
Journal:  Brain Res       Date:  1990-01-22       Impact factor: 3.252

View more
  12 in total

1.  Selective knockout of the casein kinase 2 in d1 medium spiny neurons controls dopaminergic function.

Authors:  Heike Rebholz; Mingming Zhou; Angus C Nairn; Paul Greengard; Marc Flajolet
Journal:  Biol Psychiatry       Date:  2013-01-03       Impact factor: 13.382

2.  Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity.

Authors:  I Dominguez; J M Cruz-Gamero; V Corasolla; N Dacher; S Rangasamy; A Urbani; V Narayanan; H Rebholz
Journal:  Hum Genet       Date:  2021-05-04       Impact factor: 4.132

3.  CK2 alpha prime and alpha-synuclein pathogenic functional interaction mediates synaptic dysregulation in huntington's disease.

Authors:  Dahyun Yu; Nicole Zarate; Angel White; De'jah Coates; Wei Tsai; Carmen Nanclares; Francesco Cuccu; Johnny S Yue; Taylor G Brown; Rachel H Mansky; Kevin Jiang; Hyuck Kim; Tessa Nichols-Meade; Sarah N Larson; Katherine Gundry; Ying Zhang; Cristina Tomas-Zapico; Jose J Lucas; Michael Benneyworth; Gülin Öz; Marija Cvetanovic; Alfonso Araque; Rocio Gomez-Pastor
Journal:  Acta Neuropathol Commun       Date:  2022-06-03       Impact factor: 7.578

Review 4.  Regulation of cellular proliferation in acute lymphoblastic leukemia by Casein Kinase II (CK2) and Ikaros.

Authors:  Chandrika Gowda; Chunhua Song; Malika Kapadia; Jonathon L Payne; Tommy Hu; Yali Ding; Sinisa Dovat
Journal:  Adv Biol Regul       Date:  2016-09-18

5.  De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features.

Authors:  Volkan Okur; Megan T Cho; Lindsay Henderson; Kyle Retterer; Michael Schneider; Shannon Sattler; Dmitriy Niyazov; Meron Azage; Sharon Smith; Jonathan Picker; Sharyn Lincoln; Mark Tarnopolsky; Lauren Brady; Hans T Bjornsson; Carolyn Applegate; Amy Dameron; Rebecca Willaert; Berivan Baskin; Jane Juusola; Wendy K Chung
Journal:  Hum Genet       Date:  2016-04-05       Impact factor: 4.132

6.  Critical role of Casein kinase 2 in hepatitis C NS5A-mediated inhibition of Kv2.1 K(+) channel function.

Authors:  Katerina Clemens; Chung-Yang Yeh; Elias Aizenman
Journal:  Neurosci Lett       Date:  2015-10-17       Impact factor: 3.046

7.  Identification of a Novel CSNK2A1-PDGFRB Fusion Gene in a Patient with Myeloid Neoplasm with Eosinophilia.

Authors:  Xiaoyu Xu; Qiongyu Lu; Zheng Wang; Ping Cai; Zhao Zeng; Ling Zhang; Man Wang; Liang Ma; Changgeng Ruan; Suning Chen
Journal:  Cancer Res Treat       Date:  2020-12-24       Impact factor: 4.679

8.  CSNK2B: A broad spectrum of neurodevelopmental disability and epilepsy severity.

Authors:  Michelle E Ernst; Evan H Baugh; Amanda Thomas; Louise Bier; Natalie Lippa; Nicholas Stong; Maureen S Mulhern; Sulagna Kushary; Cigdem I Akman; Erin L Heinzen; Raymond Yeh; Weimin Bi; Neil A Hanchard; Lindsay C Burrage; Magalie S Leduc; Josephine S C Chong; Renee Bend; Michael J Lyons; Jennifer A Lee; Pim Suwannarat; Eva Brilstra; Marleen Simon; Marije Koopmans; Ellen van Binsbergen; Daniel Groepper; Julie Fleischer; Caroline Nava; Boris Keren; Cyril Mignot; Sophie Mathieu; Grazia M S Mancini; Suneeta Madan-Khetarpal; Elena M Infante; Judith Bluvstein; Andrea Seeley; Kristine Bachman; Eric W Klee; Laura E Schultz-Rogers; Linda Hasadsri; Sarah Barnett; Marissa S Ellingson; Matthew J Ferber; Vinodh Narayanan; Keri Ramsey; Anita Rauch; Pascal Joset; Katharina Steindl; Theodore Sheehan; Annapurna Poduri; Alejandra Vasquez; Claudia Ruivenkamp; Susan M White; Lynn Pais; Kristin G Monaghan; David B Goldstein; Tristan T Sands; Vimla Aggarwal
Journal:  Epilepsia       Date:  2021-05-26       Impact factor: 6.740

Review 9.  CK2-An Emerging Target for Neurological and Psychiatric Disorders.

Authors:  Julia Castello; Andre Ragnauth; Eitan Friedman; Heike Rebholz
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-05

10.  Refining the clinical phenotype of Okur-Chung neurodevelopmental syndrome.

Authors:  Moe Akahira-Azuma; Yoshinori Tsurusaki; Yumi Enomoto; Jun Mitsui; Kenji Kurosawa
Journal:  Hum Genome Var       Date:  2018-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.